Aller au contenu principal
Accès ouvert déclaré 2026 article

Calcium signaling pathway implicates a shared genetic basis between psychiatric and cardiovascular diseases

0Citations signalées, ce qui n’est pas une note de qualité
4Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Psychiatric and cardiovascular diseases (CVDs) are frequently comorbid and are interconnected through the brain-heart axis. However, the underlying shared genetic etiology remains unknown in East Asians. To address this critical gap, we conducted a genome-wide pairwise trait pleiotropy study by leveraging genome-wide association studies of three major psychiatric disorders (schizophrenia [SCZ], bipolar disorder [BIP], major depressive disorder [MDD]) and ten cardiovascular traits (including eight CVDs) in East Asians. We identified genetic overlaps across seven disease pairs, such as SCZ with coronary artery disease. Through this pairwise approach, six of a total of 18 pleiotropic loci demonstrated tissue-specific expression in brain and cardiovascular systems. In the cross-ancestry replication, nine of the pleiotropic loci were validated. Among the novel pleiotropic genes, TPCN1, CACNA2D2, CACNA1D, and ATP2B1 are involved in voltage-dependent calcium channel activity, regulation of calcium influx, enriched in calcium-related pathway. We validated association with calcium signal pathway in an independent cohort. Calcium pathway-specific polygenic risk score for SCZ was associated with prolonged corrected QT (QTc) interval, which remained robust among individuals free from QTc-affecting drugs. Given that calcium-channel blockers are commonly prescribed for heart and blood vessel conditions, we performed drug target analysis by integrating gene expression profiles from the brain and cardiovascular tissues. Our findings implicated that calcium-channel blockers and peripheral vasodilators elevated SCZ risk, diuretics reduced the risks of SCZ, BIP, and MDD. Our study reveals extensive shared genetic architectures underlying psychiatric and CVDs, which warrant prudence in the use of calcium channel blockers among patients with concurrent psychiatric and CVDs.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Calcium signaling pathway implicates a shared genetic basis between psychiatric and cardiovascular diseases
Date Crossref
11/07/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Genetic Associations and EpidemiologyNeurotransmitter Receptor Influence on BehaviorFunctional Brain Connectivity Studies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.